TScan Therapeutics Formed to Overcome Challenges of Current Immunotherapies with Novel TCR Discovery Platform and $48 Million in Funding July 24, 2019
Axial Therapeutics Announces First Patient Dosed in Phase 1b/2a Clinical Trial of AB-2004 for Treatment of Gastrointestinal Dysfunction and Associated Behavioral Symptoms of Autism Spectrum Disorder July 16, 2019
Pulmocide Announces Nature Research Publication Showing PC945 in Combination with Standard Antifungal Treatment Causes a Synergistic Effect Against Aspergillus Fumigatus July 8, 2019
